These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24758628)

  • 21. Treatment of latent tuberculosis infection.
    Parekh MJ; Schluger NW
    Ther Adv Respir Dis; 2013 Dec; 7(6):351-6. PubMed ID: 24056289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis preventive therapy for HIV-infected persons in less developed countries.
    Kritski AL
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S76-81. PubMed ID: 10688154
    [No Abstract]   [Full Text] [Related]  

  • 23. Isoniazid to prevent first and recurrent episodes of TB.
    Ayles H; Muyoyeta M
    Trop Doct; 2006 Apr; 36(2):83-6. PubMed ID: 16611439
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoniazid prevention of HIV-associated tuberculosis.
    Rangaka MX; Wilkinson RJ
    Lancet Infect Dis; 2013 Oct; 13(10):825-7. PubMed ID: 23954451
    [No Abstract]   [Full Text] [Related]  

  • 25. For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance.
    Cobelens FG
    Sci Transl Med; 2013 Apr; 5(180):180fs12. PubMed ID: 23576813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Use of isoniazid chemoprophylaxis in renal transplantation.
    Ahmad R
    Nephrol Dial Transplant; 2010 Jun; 25(6):2038; author reply 2038. PubMed ID: 20305134
    [No Abstract]   [Full Text] [Related]  

  • 27. Comment on "Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis".
    Ukwaja KN
    Sci Transl Med; 2013 Sep; 5(204):204le3. PubMed ID: 24068733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis in patients with systemic lupus erythematosus.
    Mani MK
    J Assoc Physicians India; 1999 Jul; 47(7):747-8. PubMed ID: 10778610
    [No Abstract]   [Full Text] [Related]  

  • 29. Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study.
    Teklay G; Teklu T; Legesse B; Tedla K; Klinkenberg E
    BMC Public Health; 2016 Aug; 16(1):840. PubMed ID: 27543096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitored isoniazid prophylaxis for low-risk tuberculin reactors.
    Moulding T
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):1048. PubMed ID: 9625675
    [No Abstract]   [Full Text] [Related]  

  • 31. Isoniazid prophylaxis in end-stage renal disease.
    Bal AM
    Transpl Infect Dis; 2006 Dec; 8(4):242-3; author reply 243. PubMed ID: 17116141
    [No Abstract]   [Full Text] [Related]  

  • 32. Protecting young healthcare trainees from tuberculosis: can we overcome apathy?
    Pai M; Christopher DJ
    Natl Med J India; 2011; 24(4):198-200. PubMed ID: 22208137
    [No Abstract]   [Full Text] [Related]  

  • 33. A tuberculin screening and isoniazid preventive therapy program in an inner-city population.
    Bock NN; Metzger BS; Tapia JR; Blumberg HM
    Am J Respir Crit Care Med; 1999 Jan; 159(1):295-300. PubMed ID: 9872853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Question from the clinician: tuberculosis prophylaxis.
    Wald E
    Pediatr Rev; 2003 Oct; 24(10):355. PubMed ID: 14523162
    [No Abstract]   [Full Text] [Related]  

  • 35. Preventive therapy for tuberculous infection: an intervention in need of improvement.
    Snider DE; Farer LS
    Am Rev Respir Dis; 1984 Sep; 130(3):355-6. PubMed ID: 6476585
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term outcome of isoniazid prophylaxis against tuberculosis in Chinese renal transplant recipients.
    Lui SL; Li FK; Choy BY; Chan TM; Lo WK; Lai KN
    Transpl Infect Dis; 2004 Mar; 6(1):55-6. PubMed ID: 15225230
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why are people living with HIV still dying of tuberculosis?
    Godfrey-Faussett P; Ayles H
    Lancet; 2016 Mar; 387(10024):1141-3. PubMed ID: 27025319
    [No Abstract]   [Full Text] [Related]  

  • 39. Is INH alone enough for prophylaxis.
    Sanklecha MU; Raghavan K; Mehta MN
    Indian Pediatr; 1995 Jan; 32(1):105. PubMed ID: 8617518
    [No Abstract]   [Full Text] [Related]  

  • 40. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis.
    Fallab-Stubi CL; Zellweger JP; Sauty A; Uldry C; Iorillo D; Burnier M
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):525-30. PubMed ID: 9661817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.